Just Over the Horizon: Catheter Delivery of Stem Cell Therapy
Author:
Mir Osman,Savitz Sean I.
Publisher
Springer New York
Reference30 articles.
1. Ifejika-Jones NL, Barrett AM. Rehabilitation – emerging technologies, innovative therapies, and future objectives. Neurotherapeutics. 2011;8:452.
2. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011;109:923–40.
3. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, Lu M, Zhu Z, Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003;92:692–9.
4. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke. 2008;39:924–8.
5. Mattle HP, Savitz SI. Advances in emerging therapies 2010. Stroke. 2011;42:298–300.